Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.

An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...

Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to ...

President Donald Trump reached a trade deal with Japan that will impose 15% tariffs on US imports from the country, including ...

WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go ...

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

Tariffs, including the 15% rate for most imports from the EU, would raise consumer prices by 1.8% in the short run, according ...

Higher "reciprocal" tariffs are expected to go into effect this Friday. A few trade deals could still be struck with trading ...

Both sides hailed the agreement as the biggest ever. But it will come at a cost to the European Union, and many details have ...